Bradley Layton, PhD, Named Fellow of International Society for Pharmacoepidemiology

Share on: 

Bradley Layton, PhD, FISPEIt is with pleasure that we announce Bradley Layton, PhD, Director of Epidemiology at RTI Health Solutions has been named a fellow of the International Society for Pharmacoepidemiology (FISPE). He will be acknowledged as a new fellow during the 2022 ICPE Conference. Bradley was recommended for this honor by a committee of his peers and awarded this honor by the ISPE Board of Directors. FISPE status recognizes those with leadership roles in the field of pharmacoepidemiology, service to IPSE, and high professional standing.  

Bradley has been a member of ISPE since 2011 and has served in numerous capacities, such as chairing the Vaccine Special Interest Group, chairing the Spotlight Poster Sessions at ICPE, and serving on the Scientific Program Committee, Public Policy Committee, and RWE Task Force. 

“I have attended ICPE since I was a student, and ISPE has become my professional home. I am thrilled by this recognition, and I look forward to contributing to ISPE with colleagues and friends for years to come,” shared Bradley. 

Bradley has over 10 years of experience in the field of pharmacoepidemiology. His experience and publications span many therapeutic areas, including kidney disease, cardiovascular disease, diabetes, men’s health, vaccines, and pregnancy. He is also experienced in multidatabase and multinational studies. Bradley is a highly regarded lecturer on observational study design, large database utilization, and propensity score analysis. Read more about Bradley’s experience on his bio page

Congratulations, Bradley!